These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil. Yanagisawa T, Teshigawara T, Taira N. Br J Pharmacol; 1990 Sep; 101(1):157-65. PubMed ID: 2149290 [Abstract] [Full Text] [Related]
30. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide. Imagawa J, Akima M, Nabata H, Taira N. J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676 [Abstract] [Full Text] [Related]
36. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo. Kamijo T, Iwai T, Haruta K, Takeda K. Arch Int Pharmacodyn Ther; 1996 Aug; 331(3):273-84. PubMed ID: 9124999 [Abstract] [Full Text] [Related]